Cardiac magnetic resonance tomography in hypertrophic left ventricular phenotype

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022048

Enrollment

130

Registered

2020-05-29

Start date

2020-07-27

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I42.2 E85.4

Interventions

Group 1: Retrospective analysis (08/2017 - 05/2020) of patients with hypertrophic left ventricular phenotype by cardiac magnetic resonance tomography

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with hypertrophic left ventricular phenotype (> 12mm wall thickness)

Exclusion criteria

Exclusion criteria: Incomplete or insufficient cardiac magnetic resonance tomography dataset, absence of a final cardiac diagnosis, ischemic scar, acute myocarditis, disagreement of the patient for scintific use of personal or medical data

Design outcomes

Primary

Measure	Time frame
Differential diagnosis by using cardiac magnetic resonance tomography of patients with hypertrophic left ventricular phenotype, particularly cardiac amyloidosis vs. hypertrophic cardiomyopathie vs. hypertensive heart disease	—

Secondary

Measure	Time frame
Cardiac and extra-cardiac characteristics of patients with hypertrophic left ventricular phenotype, i.e. cardiac amyloidosis, hypertrophic cardiomyopathy and hypertensive heart disease	—

Countries

Germany

Contacts

Public ContactDaniel Lavall

Klinik und Poliklinik für Kardiologie Universitätsklinikum Leipzig

Daniel.Lavall@medizin.uni-leipzig.de0341-9712650

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 15, 2026